Begin main content

Defining "Decision-Grade Real World Evidence” and its Role in the Canadian Context: A Design Sprint — Pre-Conference Workshop / CAPT Annual Conference

October 21, 2018
CADTH, in partnership with Health Canada, the Institute of Health Economics (IHE), and the Canadian Association for Population Therapeutics (CAPT) is hosting a special workshop to solicit input from stakeholders into the development of frameworks for the use of real world evidence in regulatory and reimbursement decision-making. The daylong inte...

CADTH Drug Portfolio Information Session

November 1, 2018
This annual session is an opportunity for all interested stakeholders to get the latest information about priority initiatives and process changes from CADTH’s pharmaceutical reviews portfolio, including the CADTH Common Drug Review (CDR), the CADTH pan-Canadian Oncology Drug Review (pCODR), and Therapeutic Reviews. Updates on other relevant CAD...

CADTH Medical Devices Portfolio Information Session

November 1, 2018
Health technology assessment (HTA) plays a key role in decisions about the use of medical devices in Canada. This session will cover the role of HTA in the management of medical devices in Canada, the programs in CADTH’s medical devices and clinical interventions portfolio, the assessment processes CADTH follows, and the opportunities for input ...

2019 CADTH Symposium

April 14, 2019 - April 16, 2019
CADTH will be hosting its annual Symposium at the Shaw Centre in Edmonton, Alberta, from April 14 to 16, 2019. For more information, please visit the CADTH Symposium website. Questions may be sent by email to